ES2191840T3 - Nuevos derivados de aminoacidos y su utilizacion como inhibidores de trombina. - Google Patents

Nuevos derivados de aminoacidos y su utilizacion como inhibidores de trombina.

Info

Publication number
ES2191840T3
ES2191840T3 ES97926356T ES97926356T ES2191840T3 ES 2191840 T3 ES2191840 T3 ES 2191840T3 ES 97926356 T ES97926356 T ES 97926356T ES 97926356 T ES97926356 T ES 97926356T ES 2191840 T3 ES2191840 T3 ES 2191840T3
Authority
ES
Spain
Prior art keywords
amino acids
thrombin inhibitors
new derivatives
thrombin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97926356T
Other languages
English (en)
Spanish (es)
Inventor
David Gustafsson
Jan-Erik Nystrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of ES2191840T3 publication Critical patent/ES2191840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
ES97926356T 1996-06-07 1997-06-05 Nuevos derivados de aminoacidos y su utilizacion como inhibidores de trombina. Expired - Lifetime ES2191840T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9602263A SE9602263D0 (sv) 1996-06-07 1996-06-07 New amino acid derivatives

Publications (1)

Publication Number Publication Date
ES2191840T3 true ES2191840T3 (es) 2003-09-16

Family

ID=20402928

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97926356T Expired - Lifetime ES2191840T3 (es) 1996-06-07 1997-06-05 Nuevos derivados de aminoacidos y su utilizacion como inhibidores de trombina.

Country Status (26)

Country Link
US (2) US6255301B1 (cg-RX-API-DMAC10.html)
EP (1) EP0910573B1 (cg-RX-API-DMAC10.html)
JP (1) JP4237824B2 (cg-RX-API-DMAC10.html)
CN (1) CN1129604C (cg-RX-API-DMAC10.html)
AR (1) AR008046A1 (cg-RX-API-DMAC10.html)
AT (1) ATE231883T1 (cg-RX-API-DMAC10.html)
AU (1) AU723420B2 (cg-RX-API-DMAC10.html)
BR (1) BR9709560A (cg-RX-API-DMAC10.html)
CA (1) CA2255625A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ398698A3 (cg-RX-API-DMAC10.html)
DE (1) DE69718791T2 (cg-RX-API-DMAC10.html)
DK (1) DK0910573T3 (cg-RX-API-DMAC10.html)
EE (1) EE9800425A (cg-RX-API-DMAC10.html)
ES (1) ES2191840T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0002404A3 (cg-RX-API-DMAC10.html)
ID (1) ID17016A (cg-RX-API-DMAC10.html)
IL (2) IL127325A0 (cg-RX-API-DMAC10.html)
IS (1) IS4906A (cg-RX-API-DMAC10.html)
NO (1) NO317135B1 (cg-RX-API-DMAC10.html)
NZ (1) NZ332964A (cg-RX-API-DMAC10.html)
PL (1) PL330482A1 (cg-RX-API-DMAC10.html)
SE (1) SE9602263D0 (cg-RX-API-DMAC10.html)
SK (1) SK165398A3 (cg-RX-API-DMAC10.html)
TR (1) TR199802536T2 (cg-RX-API-DMAC10.html)
WO (1) WO1997046577A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA974542B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AR013084A1 (es) 1997-06-19 2000-12-13 Astrazeneca Ab Derivados de amidino utiles como inhibidores de la trombina, composicion farmaceutica, utilizacion de dichos compuestos para la preparacion demedicamentos y proceso para la preparacion de los compuestos mencionados
SE9704543D0 (sv) 1997-12-05 1997-12-05 Astra Ab New compounds
WO1999055355A1 (en) 1998-04-24 1999-11-04 3-Dimensional Pharmaceuticals, Inc. Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
SE9804313D0 (sv) 1998-12-14 1998-12-14 Astra Ab New compounds
DK1150996T3 (da) * 1999-01-13 2008-02-11 Astrazeneca Ab Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
SE9902270D0 (sv) * 1999-06-16 1999-06-16 Astra Ab Pharmaceutically active compounds
SE0001803D0 (sv) 2000-05-16 2000-05-16 Astrazeneca Ab New compounds i
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
ES2311538T3 (es) * 2000-08-16 2009-02-16 Astrazeneca Ab Nuevos derivados amidino y su uso como inhibidores de trombina.
US7129233B2 (en) 2000-12-01 2006-10-31 Astrazeneca Ab Mandelic acid derivatives and their use as thrombin inhibitors
RU2300521C2 (ru) * 2000-12-01 2007-06-10 Астразенека Аб Новые производные миндальной кислоты и их применение в качестве ингибиторов тромбина
AR035216A1 (es) * 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
AR034517A1 (es) 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
US7781424B2 (en) * 2003-05-27 2010-08-24 Astrazeneca Ab Modified release pharmaceutical formulation
TW200827336A (en) * 2006-12-06 2008-07-01 Astrazeneca Ab New crystalline forms
US20090061000A1 (en) * 2007-08-31 2009-03-05 Astrazeneca Ab Pharmaceutical formulation use 030
PT2242759E (pt) 2008-02-06 2012-12-17 Astrazeneca Ab Compostos
GB0913342D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab Compounds - 801
KR101181918B1 (ko) * 2010-11-09 2012-09-11 주식회사 세라젬 온열치료기용 상하운동 조절장치
EP3052498A1 (en) 2013-09-30 2016-08-10 Council of Scientific & Industrial Research 3,7-diazabicyclo[3.3.1]nonane carboxamides as antithrombotic agents
EP3102200B1 (en) * 2014-02-07 2023-04-05 Exithera Pharmaceuticals Inc. Therapeutic compounds and compositions
CN108530297B (zh) * 2017-03-03 2021-09-24 联化科技股份有限公司 2-氯-3-甲基苯甲酸及其中间体的制备方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
HU192646B (en) 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
CA1341029C (en) 1985-02-04 2000-06-20 Michael Kolb Peptidase inhibitors
US5187157A (en) 1987-06-05 1993-02-16 Du Pont Merck Pharmaceutical Company Peptide boronic acid inhibitors of trypsin-like proteases
EP0362002B1 (en) 1988-09-01 1995-07-26 Merrell Dow Pharmaceuticals Inc. HIV protease inhibitors
ZA897514B (en) 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
TW201303B (cg-RX-API-DMAC10.html) 1990-07-05 1993-03-01 Hoffmann La Roche
CA2075154A1 (en) 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
SE9102462D0 (sv) 1991-08-28 1991-08-28 Astra Ab New isosteric peptides
CZ333492A3 (en) 1991-11-12 1993-09-15 Lilly Co Eli Dipeptide of l-azetidine-2-carboxylic acids and l-argininaldehyde, process of its preparation and pharmaceutical preparation in which said dipeptide is comprised
SE9103612D0 (sv) 1991-12-04 1991-12-04 Astra Ab New peptide derivatives
US5760235A (en) 1992-03-04 1998-06-02 Gyogyszerkutato Intezet Kft. Anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for preparation thereof
TW223629B (cg-RX-API-DMAC10.html) 1992-03-06 1994-05-11 Hoffmann La Roche
AU675981B2 (en) 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
US5583146A (en) 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
JPH06340619A (ja) 1993-05-03 1994-12-13 Bristol Myers Squibb Co グアニジニルまたはアミジニル置換メチルアミノ複素環トロンビン抑制剤
US5780631A (en) 1993-06-03 1998-07-14 Astra Aktiebolag Starting materials in the synthesis of thrombin and kininogenase inhibitors
SE9301916D0 (sv) 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
EP0648780A1 (en) 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
TW394760B (en) 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
AU1025795A (en) 1994-01-27 1995-08-03 Mitsubishi Chemical Corporation Prolineamide derivatives
US5707966A (en) 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5726159A (en) 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5705487A (en) 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
IL112795A (en) * 1994-03-04 2001-01-28 Astrazeneca Ab Peptide derivatives as antithrombic agents their preparation and pharmaceutical compositions containing them
US5561146A (en) 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
DE4421052A1 (de) * 1994-06-17 1995-12-21 Basf Ag Neue Thrombininhibitoren, ihre Herstellung und Verwendung
US5510369A (en) 1994-07-22 1996-04-23 Merck & Co., Inc. Pyrrolidine thrombin inhibitors
DE4443390A1 (de) 1994-12-06 1996-06-13 Basf Ag Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten
CA2210989A1 (en) 1995-02-10 1996-08-15 Basf Aktiengesellschaft Thrombin inhibitors
KR100388185B1 (ko) * 1995-02-17 2003-11-28 애보트 게엠베하 운트 콤파니 카게 트롬빈 억제제로서의 신규 디펩티드 아미딘
US5710130A (en) 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
AU698911B2 (en) 1995-04-04 1998-11-12 Merck & Co., Inc. Thrombin inhibitors
US5629324A (en) 1995-04-10 1997-05-13 Merck & Co., Inc. Thrombin inhibitors
SA96170106A (ar) 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
AR005245A1 (es) 1995-12-21 1999-04-28 Astrazeneca Ab Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion
JPH1095898A (ja) 1996-09-25 1998-04-14 Sumitomo Bakelite Co Ltd 難燃性樹脂組成物およびこれを用いた積層板
DE19632772A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Benzamidine
DE19632773A1 (de) 1996-08-14 1998-02-19 Basf Ag Neue Thrombininhibitoren
SE9704543D0 (sv) * 1997-12-05 1997-12-05 Astra Ab New compounds

Also Published As

Publication number Publication date
IS4906A (is) 1998-11-25
CN1129604C (zh) 2003-12-03
NO985700L (no) 1999-02-05
CN1226895A (zh) 1999-08-25
NZ332964A (en) 2000-08-25
US6255301B1 (en) 2001-07-03
HUP0002404A3 (en) 2001-02-28
SE9602263D0 (sv) 1996-06-07
US20020019371A1 (en) 2002-02-14
CA2255625A1 (en) 1997-12-11
CZ398698A3 (cs) 1999-07-14
ZA974542B (en) 1997-12-08
US6838478B2 (en) 2005-01-04
SK165398A3 (en) 1999-08-06
HUP0002404A2 (hu) 2000-10-28
PL330482A1 (en) 1999-05-24
IL127325A (en) 2006-10-31
DE69718791D1 (de) 2003-03-06
EP0910573B1 (en) 2003-01-29
ID17016A (id) 1997-12-04
AU3114097A (en) 1998-01-05
EE9800425A (et) 1999-06-15
BR9709560A (pt) 1999-08-10
DE69718791T2 (de) 2003-10-23
WO1997046577A1 (en) 1997-12-11
DK0910573T3 (da) 2003-06-23
AU723420B2 (en) 2000-08-24
NO317135B1 (no) 2004-08-23
AR008046A1 (es) 1999-12-09
JP4237824B2 (ja) 2009-03-11
TR199802536T2 (xx) 1999-03-22
JP2000512631A (ja) 2000-09-26
ATE231883T1 (de) 2003-02-15
EP0910573A1 (en) 1999-04-28
NO985700D0 (no) 1998-12-04
IL127325A0 (en) 1999-09-22

Similar Documents

Publication Publication Date Title
ES2191840T3 (es) Nuevos derivados de aminoacidos y su utilizacion como inhibidores de trombina.
ES2128283T1 (es) Profarmacos de inhibidores de trombina.
SE9602646D0 (sv) Pharmaceutically-useful compounds
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
MY116539A (en) New amino acid derivatives
ES2183882T3 (es) Inhibidores de trombina.
SV1995000074A (es) Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de la matriz
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
BR0016878A (pt) Inibidores tricìclicos de cinases protéicas
ATE136888T1 (de) Retrovirale proteaseinhibitoren
DK1273299T3 (da) Minoxidilinindeholdende praparater
ATE274521T1 (de) Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
IS5511A (is) Ný efnasambönd
SE9804313D0 (sv) New compounds
ATE211719T1 (de) Korrosionsinhibitoren enthaltender injektionszement
ATE407116T1 (de) Neue amidino-derivate und deren verwendung als thrombin-inhibitoren
ATE317384T1 (de) Lta4 hydrolase-hemmer
BR9803717A (pt) ácidos indol-2-carbocìlicos substituìdos como inibidores de glucosil transferase.
ES2185154T3 (es) Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia.
ATE292970T1 (de) Topische zusammensetzung enthaltend brucin und ihre verwendung zur behandlung von hautschäden